You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.



Test Your Knowledge: Fibrodysplasia Ossificans Progressiva

  • Authors: Robert J. Pignolo, MD, PhD
  • CME Released: 1/27/2021
  • Valid for credit through: 1/27/2022, 11:59 PM EST
Start Activity

Target Audience and Goal Statement

This activity is intended for orthopedists, orthopedic surgeons, rheumatologists, endocrinologists, oncologists, primary care physicians, pediatricians, geneticists, and other healthcare providers involved in the management of FOP. 

The goal of this activity is to close the gaps related to the diagnosis and treatment of fibrodysplasia ossificans progressiva (FOP).

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Signs and symptoms of FOP
  • Self-assess learning needs related to
    • Current and emerging treatments for FOP


As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


  • Robert Pignolo, MD, PhD

    Geriatric Medicine and Gerontology
    Robert and Arlene Kogod Professor of Geriatric Medicine
    Mayo Clinic College of Medicine
    Rochester, Minnesota


    Disclosure: Robert J. Pignolo, MD, PhD, has disclosed the following relevant financial relationships:
    Received grants for clinical research from: Clementia; Ipsen; Regeneron


  • Karen Badal, MD, MPH

    Senior Medical Education Director, Medscape, LLC


    Disclosure: Karen Badal, MD, MPH, has disclosed the following relevant financial relationships:
    Owns stock, stock options or bonds from: Kallyope, Inc

  • Frances McFarland, PhD, MA

    Medical Writer, WebMD Global, LLC


    Disclosure: Frances McFarland, PhD, MA, has disclosed no relevant financial relationships.

CME Reviewer

  • Robert Morris, PharmD

    Associate Director, Accreditation and Compliance, Medscape, LLC 


    Disclosure: Robert Morris, PharmD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: ViiV Healthcare
    Owns stock, stock options, or bonds from: GlaxoSmithKline

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

Accreditation Statements



Developed through a partnership between Medscape and the International Fibrodysplasia Ossificans Progressiva Association (IFOPA).


Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


Test Your Knowledge: Fibrodysplasia Ossificans Progressiva

Authors: Robert J. Pignolo, MD, PhDFaculty and Disclosures

CME Released: 1/27/2021

Valid for credit through: 1/27/2022, 11:59 PM EST


The goals of continuing medical education (CME) and professional development are to acquire and retain knowledge that will enhance clinical practice and improve patient outcomes. The following self-assessment survey is offered for CME credit and is designed to test your current knowledge and skills related to recognizing and managing fibrodysplasia ossificans progressiva (FOP).

  • Print